Vitamin D3 and K2 are among the most widely researched supplement combinations available, and for most healthy adults they are well tolerated at standard doses. But “generally safe” and “no considerations” are not the same thing — there are specific interactions, upper limits, and population groups that warrant attention before supplementing.
This guide covers the side effects profile of D3K2 supplementation, the most clinically significant interaction (with anticoagulant medication), vitamin D upper limits, and who should take extra care. For the full overview of benefits and how D3 and K2 work together, see our complete D3 and K2 benefits guide. For dosage, ratio and how to take them, see our D3 and K2 dosage and ratio guide.
Are there side effects of taking vitamin D3 and K2 together?
At standard supplementation doses — 1,000–2,000 IU of vitamin D3 with 100–200mcg of K2 MK-7 — there are no well-documented adverse effects in healthy adults. Both vitamins have strong safety records in clinical trials.
Vitamin K2 has no established tolerable upper intake level. Studies using doses of 180–360mcg MK-7 daily over periods of two to three years have found it to be safe and well-tolerated, with no significant adverse events. Japanese populations consuming high amounts of K2 through natto have not shown elevated rates of adverse effects attributed to K2.
Vitamin D3 does have an established EFSA upper limit of 4,000 IU daily for adults. At doses well above this, taken over extended periods, vitamin D toxicity can occur — but this requires sustained intake significantly higher than typical supplementation levels.
The main interaction: vitamin K2 and anticoagulant medication
The most clinically significant concern with vitamin K2 supplementation is its interaction with warfarin (coumadin) and other coumarin-based anticoagulants. Warfarin works by inhibiting the vitamin K-dependent activation of clotting factors. Vitamin K2 competes directly with this mechanism — supplementing K2 while on warfarin can reduce the drug’s anticoagulant effect and alter INR levels in ways that are difficult to predict without close monitoring.
This applies to both K1 and K2, and to all forms of K2 including MK-4 and MK-7. Even small amounts of additional vitamin K can shift INR in people whose anticoagulation is tightly managed. Do not supplement with any form of vitamin K while on warfarin without first speaking to your GP or anticoagulation clinic.
The picture with direct oral anticoagulants (DOACs) such as rivaroxaban and apixaban is less clear — these drugs work through a different mechanism and do not depend on vitamin K antagonism. Current evidence does not indicate the same interaction, but data is limited and a cautious approach is reasonable. If you take any anticoagulant medication, discuss supplementation with your GP before starting.
Vitamin D3 toxicity: how much is too much?
Vitamin D toxicity — hypervitaminosis D — results in hypercalcaemia: excess calcium in the blood. The pathway is straightforward: very high D3 doses drive calcium absorption beyond what the body’s regulatory mechanisms can manage, causing calcium to accumulate in blood and soft tissue.
In practice, toxicity at doses below 10,000 IU daily is rare in healthy adults. The NHS advises against taking more than 4,000 IU daily without medical supervision, and the EFSA sets the tolerable upper level at this dose. People correcting confirmed deficiency are sometimes prescribed higher doses (10,000–50,000 IU) under GP monitoring for limited periods — this is distinct from ongoing supplementation.
Symptoms of vitamin D toxicity include nausea, vomiting, weakness, frequent urination, confusion, and in severe cases, kidney damage. If you supplement at doses above 4,000 IU daily, periodic blood testing (25-OH vitamin D; optimal range 50–125 nmol/L) is a sensible precaution. Levels consistently above 150 nmol/L suggest excess.
What not to take with vitamin D3
Beyond the K2–warfarin interaction covered above, several medications and supplement combinations warrant attention when taking vitamin D3. None are outright contraindications for most people, but timing and dose matter.
Thiazide diuretics
Thiazide diuretics (bendroflumethiazide, hydrochlorothiazide, indapamide) reduce urinary calcium excretion. Combined with high-dose vitamin D3, which increases calcium absorption, this can push blood calcium into the hypercalcaemic range in susceptible people. At standard D3 doses (1,000–2,000 IU) the risk is low, but if you take a thiazide and are considering D3 above 2,000 IU daily, periodic calcium monitoring is sensible.
High-dose calcium supplements without K2
Vitamin D3 increases the absorption of dietary and supplemental calcium. For how vitamin D works with other minerals, see our article on vitamin D with zinc and magnesium. Pairing D3 with a high-dose calcium supplement (1,000+ mg) without adequate K2 is the combination most strongly linked to concerns about arterial calcification. K2 MK-7 activates Matrix Gla Protein, which prevents calcium from depositing in soft tissue — for more on this, see our guide to bone health. If you take calcium, take K2 alongside it — this is the evidence-supported approach.
Orlistat and other fat-blocking agents
Orlistat (Xenical, Alli) reduces dietary fat absorption, which directly reduces absorption of all fat-soluble vitamins including D3. If you take orlistat, separate your D3 supplement from it by at least 2 hours, and take D3 with a fat-containing meal at a different time of day.
Iron supplements — timing only
Iron does not directly interact with vitamin D3, but both compete with other nutrients for absorption. Taking iron with a high-calcium meal (or calcium supplement) reduces iron absorption significantly. If you supplement both, space them apart: iron on an empty stomach or with vitamin C, D3 with a separate fat-containing meal.
Corticosteroids
Long-term corticosteroids (prednisolone, dexamethasone) accelerate vitamin D breakdown and reduce calcium absorption. People on long-term steroid therapy often need higher D3 doses than standard guidance, and should have vitamin D and calcium monitored by their GP rather than self-adjusting.
Who should take extra care
Beyond anticoagulant users, several groups should consult a healthcare professional before supplementing with D3 and K2.
People with chronic kidney disease may have impaired conversion of vitamin D to its active form (calcitriol), and supplementation can be more difficult to manage in terms of dosing and calcium monitoring. People with granulomatous conditions such as sarcoidosis or tuberculosis are at higher risk of vitamin D toxicity because granuloma tissue can convert vitamin D to its active form independently of normal feedback regulation, leading to elevated calcium even at standard supplementation doses. Those with hypercalcaemia from any cause should not supplement with vitamin D3 without medical oversight.
For pregnant and breastfeeding women, vitamin D3 at standard doses (400–1,000 IU) is generally considered safe and is often actively recommended. K2 data in pregnancy is more limited; current evidence does not indicate harm at supplementation doses, but it is worth discussing with a midwife or GP if you have specific concerns.
Is vitamin K2 safe to take long term?
The available evidence suggests yes. The longest clinical trials on MK-7 supplementation have run for two to three years without safety concerns. A 2015 study published in Thrombosis and Haemostasis found MK-7 supplementation improved arterial stiffness in postmenopausal women over three years with no adverse effects reported. A 2013 trial in Osteoporosis International found similar safety over the same period at doses of 180mcg MK-7 daily.
Unlike vitamin D, which is stored in fat tissue and can build up with prolonged high doses, K2 is used by the body actively — in carboxylating osteocalcin and Matrix Gla Protein — and any surplus is excreted rather than accumulated. There is no theoretical mechanism by which K2 builds up to toxic levels in the body.
Safe dosage, in brief
For healthy adults, 1,000–2,000 IU vitamin D3 with 90–200mcg K2 MK-7 daily sits within the ranges used in clinical research. Our Vitamin D3 K2 supplement provides 4,000 IU D3 with 100mcg K2 MK-7 in an MCT oil base for optimal absorption. The EFSA upper limit for D3 is 4,000 IU daily; K2 has no established upper limit. Both are fat-soluble, so take them with a meal containing fat. For the full breakdown — ratios, timing, higher-dose guidance, and how to read a D3K2 label — see our D3 and K2 dosage and ratio guide.
Frequently asked questions
Are there side effects of vitamin D3 and K2?
At standard doses (1,000–2,000 IU D3 with 100–200mcg K2 MK-7), there are no well-documented side effects in healthy adults. The most significant concern is the interaction between K2 and warfarin — K2 can reduce warfarin’s anticoagulant effect and alter INR levels unpredictably. If you take any anticoagulant, consult your GP before supplementing with vitamin K.
What should you not take with vitamin D3?
Most combinations are fine, but a few warrant care. Avoid pairing vitamin D3 with high-dose calcium supplements (1,000+ mg) unless you’re also taking K2 MK-7. If you take thiazide diuretics, keep D3 at standard doses (≤2,000 IU) unless your GP advises otherwise, as the combination can raise blood calcium. Orlistat reduces D3 absorption — space them apart by at least 2 hours. Corticosteroids accelerate D3 breakdown and require higher doses under GP monitoring. And do not supplement with K2 (in D3K2 products) if you’re on warfarin.
Can vitamin K2 interact with warfarin?
Yes — this is the most clinically significant interaction with K2 supplementation. Warfarin works by blocking vitamin K-dependent clotting factor activation. K2 competes with this mechanism and can reduce warfarin’s effectiveness, shifting INR unpredictably. If you are on warfarin or any coumarin anticoagulant, do not supplement with K2 without first consulting your GP or anticoagulation clinic.
Can you take vitamin D3 and K2 every day?
Yes, for most healthy adults. Both nutrients are used daily by the body, and consistent supplementation helps maintain steady blood levels — particularly important for fat-soluble vitamins like D3 and K2, whose levels reflect cumulative intake rather than individual doses.
What are the signs of too much vitamin D?
Early symptoms of vitamin D toxicity include nausea, vomiting, weakness, and frequent urination. More severe cases can involve confusion, elevated blood calcium, and kidney damage. Toxicity at doses below 10,000 IU daily is rare in healthy adults; the EFSA upper limit of 4,000 IU provides a safe margin for routine supplementation.
Is MK-7 safe?
Yes, MK-7 has a strong safety record. Multi-year clinical trials using doses of 90–360mcg daily have found no significant adverse effects, and there is no established upper limit for vitamin K2. The only clinically relevant precaution is for people taking warfarin or other coumarin anticoagulants.
Can D3 and K2 cause blood clots?
No — there is no evidence that D3 and K2 at standard doses increases clotting risk in healthy adults. K2’s interaction with warfarin runs in the opposite direction: it reduces anticoagulant effect rather than increasing clotting tendency. People with clotting disorders should discuss all supplementation with their haematologist.
Is vitamin D3 and K2 safe during pregnancy?
Vitamin D3 at standard supplementation doses (400–1,000 IU) is generally considered safe during pregnancy and is often recommended by UK healthcare providers. Clinical data on K2 supplementation in pregnancy is more limited, but current evidence does not indicate harm at supplementation doses. Discuss with your midwife or GP if you have specific concerns.
References
- Knapen MHJ, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thrombosis and Haemostasis. 2015;113(5):1135–1144. doi:10.1160/TH14-08-0675
- Knapen MHJ, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International. 2013;24(9):2499–2507.
- Bolland MJ, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events. BMJ. 2011;342:d2040. doi:10.1136/bmj.d2040
- Vitamin D and Vitamin K: Synergistic Roles in Health. PMC. 2025. PMC12711164
- NHS. Vitamin D. 2023.
This article is for informational purposes only and does not constitute medical advice. If you take anticoagulant medication, have kidney disease, or are pregnant, speak with your GP before starting any vitamin D or K supplement.
